SCHEMBL5762020

SCHEMBL5762020

CCn1c(=O)c(-c2ccc3ccccc3c2)cc2cnc(Nc3ccccc3)nc21

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 6/20 0.68
EGFR P00533 2/20 0.68
RIPK2 O43353 3/20 0.64
ACVR1 Q04771 3/20 0.64
NOD2 Q9HC29 3/20 0.64
CDK4 P11802 6/20 0.62
CCND1 P24385 6/20 0.62
CCND2 P30279 6/20 0.62
CCND3 P30281 6/20 0.62
CCNB2 O95067 3/20 0.62
CCNE2 O96020 3/20 0.62
CDK1 P06493 3/20 0.62
CCNB1 P14635 3/20 0.62
CCNA2 P20248 3/20 0.62
FGFR2 P21802 3/20 0.62
FGFR4 P22455 3/20 0.62
FGFR3 P22607 3/20 0.62
CCNE1 P24864 3/20 0.62
CDK2 P24941 3/20 0.62
CCNA1 P78396 3/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5764524 0.90 FGFR1 (0.72) FGFR1EGFRRIPK2ACVR1NOD2
SCHEMBL5762208 0.90 FGFR1 (0.75) FGFR1EGFRRIPK2ACVR1NOD2
SCHEMBL5764948 0.88 CDK4 (0.56) FGFR1EGFRRIPK2ACVR1NOD2
SCHEMBL5761780 0.86 FGFR1 (0.70) FGFR1EGFRRIPK2ACVR1NOD2
SCHEMBL5763095 0.86 FGFR1 (0.70) FGFR1EGFRRIPK2ACVR1NOD2
SCHEMBL5763272 0.84 RIPK2 (0.49) FGFR1EGFRRIPK2ACVR1NOD2
SCHEMBL5762040 0.84 FGFR1 (0.66) FGFR1EGFRRIPK2ACVR1NOD2
SCHEMBL5262288 0.82 CDK4 (0.70) FGFR1EGFRRIPK2ACVR1NOD2
SCHEMBL5762083 0.81 FGFR1 (1.00) FGFR1EGFRRIPK2ACVR1NOD2
SCHEMBL14040742 0.81 RIPK2 (0.79) FGFR1EGFRRIPK2ACVR1NOD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0823908-B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2006-11-02 EP claimed
WO-2005105097-A2 PYRIDOPYRIMIDINES FOR TREATING INFLAMMATORY AND OTHER DISEASES GPC BIOTECH AG (DE) 2005-11-10 WO claimed
EP-0823908-A1 PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1998-02-18 EP claimed
WO-1996034867-A1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1996-11-07 WO claimed
EP-0823908-B1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2006-11-02 EP disclosed
WO-2005105097-A2 PYRIDOPYRIMIDINES FOR TREATING INFLAMMATORY AND OTHER DISEASES GPC BIOTECH AG (DE) 2005-11-10 WO disclosed
US-5945422-A ANTICANCER AGENTS; ATHEROSCLEROSIS; RESTENOSIS; PSORIASIS WARNER-LAMBERT COMPANY (US) 1999-08-31 US disclosed
US-5733914-A Pyrido 2, 3-d!pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation WARNER-LAMBERT COMPANY (US) 1998-03-31 US disclosed
EP-0823908-A1 PYRIDO 2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1998-02-18 EP disclosed
WO-1996034867-A1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION WARNER-LAMBERT COMPANY (US) 1996-11-07 WO disclosed